update desk

Report: Mnuchin proposes FDA branch in Israel, meets with health officials

The FDA has few branches outside the United States, including those in China, and several European and Latin American nations.

U.S. Secretary of the Treasury Steven Mnuchin. Credit: Ricky Harris/The White House.
U.S. Secretary of the Treasury Steven Mnuchin. Credit: Ricky Harris/The White House.

U.S. Treasury Secretary Steven Mnuchin met on Tuesday with Israeli health officials to discuss opening an Israeli branch of the U.S. Food and Drug Administration (FDA), a Treasury spokesperson told JNS.

Calcalist first reported the meeting.

The meeting, which included Marius Nacht, co-founder of life-sciences and health-care venture capital fund aMoon, and senior executives from Israeli health-maintenance organization Clalit and Sheba Medical Center, was held at the home of U.S. Ambassador to Israel David Friedman in Herzliya.

The FDA has few branches outside the United States, including those in China, and several European and Latin American nations.

“At first glance, Israel is too small to meet the FDA criteria for a local branch, but the matter is being considered due to the country’s unusually large concentration of biotech and medtech companies,” reported Calcalist, citing a source familiar with the matter. “While it will not replace the need to apply for FDA clearance in the U.S., it could shorten the application process for Israeli companies.”

Estimates are that such a branch could be established in Israel in the near future, the person said.

You have read 3 articles this month.
Register to receive full access to JNS.

Just before you scroll on...

Israel is at war. JNS is combating the stream of misinformation on Israel with real, honest and factual reporting. In order to deliver this in-depth, unbiased coverage of Israel and the Jewish world, we rely on readers like you. The support you provide allows our journalists to deliver the truth, free from bias and hidden agendas. Can we count on your support? Every contribution, big or small, helps JNS.org remain a trusted source of news you can rely on.

Become a part of our mission by donating today
Topics
Comments
Thank you. You are a loyal JNS Reader.
You have read more than 10 articles this month.
Please register for full access to continue reading and post comments.
Never miss a thing
Get the best stories faster with JNS breaking news updates